THE ROYAL VETERINARY COLLEGE

Their core work

The Royal Veterinary College is the UK's oldest and largest veterinary school, based in London, with deep research strengths in musculoskeletal biology, comparative biomechanics, and animal health. Their H2020 portfolio reveals a dual focus: fundamental research into bone, cartilage, and evolutionary locomotion on one side, and applied veterinary science — including vaccine development, antimicrobial alternatives for livestock, and disease therapies — on the other. They bring strong capabilities in animal models, tissue engineering, and computational biomechanics (finite element analysis, in silico modelling) that bridge veterinary medicine with human biomedical applications.

What they specialise in

How they've shifted over time

In the early H2020 period (2015–2018), RVC's work spread broadly across veterinary immunology, parasite vaccines, livestock health, and foundational musculoskeletal training networks — reflecting a generalist veterinary research profile. From 2018 onward, their focus sharpened significantly toward bone biology, biomechanics, and tissue engineering, with keywords like bone, cartilage, osteoarthritis, biomaterials, and in silico tissue repair dominating recent projects. Simultaneously, they began exploring unexpected territory: mitochondrial biology (FIRM) and navigation sensor systems (DYANS), suggesting a willingness to diversify beyond traditional veterinary boundaries.

RVC is consolidating around computational and experimental musculoskeletal research while maintaining applied veterinary capabilities in antimicrobial alternatives — expect future projects combining in silico bone modelling with translational veterinary medicine.

How they like to work

RVC operates as a balanced player — coordinating 6 of 15 projects (40%) shows genuine leadership capacity, while their 9 participant roles demonstrate comfort in specialist contributor positions within larger consortia. With 104 unique partners across 21 countries, they maintain a broad European network rather than relying on a small circle of repeat collaborators. Their coordinated projects tend to be smaller and more focused (EUR 150K–250K, often MSCA or ERC), while they join larger RIA consortia as specialist partners, suggesting they lead niche research but contribute veterinary and biomechanical expertise to bigger multi-partner efforts.

RVC has collaborated with 104 distinct partners across 21 countries, indicating a well-connected European network. As a London-based institution, they bridge UK veterinary expertise with continental European research consortia in both fundamental biology and applied animal health.

What sets them apart

RVC occupies a rare intersection: they combine deep veterinary science with advanced computational biomechanics and evolutionary biology — very few institutions can offer animal models expertise alongside finite element analysis and in silico tissue modelling. Their evolutionary locomotion work (DAWNDINOS, TETRAPODBONES) is genuinely distinctive and provides unique comparative anatomy insights applicable to orthopaedic biomaterials and regenerative medicine. For consortium builders, RVC offers the credibility of the UK's leading veterinary institution with a research portfolio that extends well beyond clinical veterinary practice into translational biomedical science.

Highlights from their portfolio

• DAWNDINOS
  Their largest project (EUR 2.5M ERC grant) testing locomotor superiority in early dinosaurs — a flagship example of RVC's unique strength in evolutionary biomechanics.
• AVANT
  Addresses the critical challenge of antimicrobial resistance in livestock through bacteriophages, gut stabilizers, and feed strategies — high commercial and policy relevance running through 2025.
• CarBon
  Bridges RVC's bone expertise with translational tissue engineering for osteoarthritis and bone defect treatment, combining experimental and computational (in silico) approaches.